Prime Medicine Inc

NAS:PRME (USA)  
$ 6.77 +0.1 (+1.5%) 11:09 PM EST
At Loss
P/B:
4.93
Market Cap:
$ 811.99M
Enterprise V:
$ 691.96M
Volume:
523.71K
Avg Vol (2M):
690.28K
Volume:
523.71K
At Loss
Avg Vol (2M):
690.28K

Business Description

Prime Medicine Inc
NAICS : 541714 SIC : 2833
ISIN : US74168J1016
Description
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Name Current Vs Industry Vs History
Cash-To-Debt 8.92
Equity-to-Asset 0.69
Debt-to-Equity 0.1
Debt-to-EBITDA -0.07
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 31.96
9-Day RSI 35.35
14-Day RSI 39.57
6-1 Month Momentum % -1.57
12-1 Month Momentum % -20.89

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.53
Quick Ratio 2.53
Cash Ratio 2.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.7
Shareholder Yield % 1.35
Name Current Vs Industry Vs History
ROE % -85.24
ROA % -71.21
ROIC % -249.12
ROC (Joel Greenblatt) % -435.1
ROCE % -78.65

Financials (Next Earnings Date:2024-05-10 Est.)

PRME's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PRME

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Prime Medicine Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.18
Beta 0
Volatility % 76.74
14-Day RSI 39.57
14-Day ATR ($) 0.555159
20-Day SMA ($) 7.6315
12-1 Month Momentum % -20.89
52-Week Range ($) 5.54 - 17.2
Shares Outstanding (Mil) 119.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Prime Medicine Inc Filings

Filing Date Document Date Form
No Filing Data

Prime Medicine Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Prime Medicine Inc Frequently Asked Questions

What is Prime Medicine Inc(PRME)'s stock price today?
The current price of PRME is $6.77. The 52 week high of PRME is $17.20 and 52 week low is $5.54.
When is next earnings date of Prime Medicine Inc(PRME)?
The next earnings date of Prime Medicine Inc(PRME) is 2024-05-10 Est..
Does Prime Medicine Inc(PRME) pay dividends? If so, how much?
Prime Medicine Inc(PRME) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1